Company: Roper Technologies, Inc. (NASDAQ: ROP) Earnings Date: July 23, 2026 (before market open) Prepared: July 22, 2026
Key Takeaway: The setup into Q2 2026 is modestly constructive — consensus sits near the low end of management's guided range, the bar is achievable, and the biggest swing factor is whether organic growth in Application Software can offset the known Q2 timing headwind in nonrecurring perpetual revenue.
Heading into Q2 2026, the bar for Roper is manageable: consensus DEPS of ~$5.28 sits just below the midpoint of management's guided range of $5.25–$5.30, and revenue consensus of ~$2.10B implies ~8% total growth, consistent with the full-year framework. Management's tone on the Q1 call was constructive but deliberately conservative — no GovCon recovery, no DAT freight recovery, and no Neptune rebound are baked into guidance, leaving meaningful optionality to the upside if any of those segments inflect. Estimate revisions have been essentially flat since the Q1 print (DEPS consensus moved from $5.31 to $5.28, a modest -0.6% drift), suggesting the Street has largely digested the Q1 beat and guidance raise without chasing numbers higher. The stock has underperformed significantly since last earnings — down ~7.4% vs. IGV +6.5% and SPY +5.5% — trading at a meaningful discount to its historical multiple, which sets up a low-expectations entry point if execution is clean. The key wildcard is the Deltek GovCon segment: any signal of enterprise deal activity resuming — even a modest uptick in perpetual license bookings — could be the catalyst that re-rates the stock, while a further delay would confirm the bear case that the portfolio's most valuable asset is structurally impaired.
Key Takeaway: Consensus is a low-to-fair bar — DEPS of $5.28 sits just below the guided midpoint of $5.275, and organic growth of ~4.3% is below management's full-year 5–6% framework, leaving room for a beat if Application Software timing normalizes and TEP holds its Q1 momentum.
KPI | Last Quarter Actual (Q1 2026) | Prior Year Period (Q2 2025 Actual) | Q2 2026 Consensus Estimate | YoY Change | Management Guidance | Consensus vs. Guidance |
Revenue (Net Sales) | $2,095M | $1,944M | $2,097M | +7.9% | ~8% total growth (FY) | In line |
Adj. DEPS (Diluted EPS — Operating) | $5.16 | $4.87 | $5.28 | +8.4% | $5.25–$5.30 (mid: $5.275) | +0.1% above mid |
EBITDA (Operating) | $797M | $775M | $816M | +5.3% | N/A — not guided explicitly | N/A |
EBITDA Margin (Operating) | 38.0% | 39.9% | 39.1% | -80 bps YoY | N/A — not guided explicitly | N/A |
Organic Revenue Growth | 6% | 7% | ~4.3% | -270 bps YoY | 5–6% FY; lower in Q2 on timing | Below FY guide; in line with Q2 commentary |
Free Cash Flow | $562M | $373M | $537M | +44% | N/A — not guided quarterly | N/A |
Sources: Visible Alpha Consensus and Actuals Data; ROP Q1 2026 Earnings Call (April 23, 2026). Q2 2026 consensus figures as of July 22, 2026. Q1 2026 actuals and Q2 2025 actuals from Visible Alpha.
Quarter | Reported | Consensus | Surprise % | Result |
Q1 2026 | $5.155 | $4.990 | +3.3% | Beat |
Q4 2025 | $5.208 | $5.138 | +1.4% | Beat |
Q3 2025 | $5.144 | $5.113 | +0.6% | Beat |
Q2 2025 | $4.874 | $4.820 | +1.1% | Beat |
Q1 2025 | $4.778 | $4.735 | +0.9% | Beat |
Q4 2024 | $4.810 | $4.757 | +1.1% | Beat |
Q3 2024 | $4.616 | $4.524 | +2.0% | Beat |
Q2 2024 | $4.476 | $4.475 | +0.0% | In Line |
ROP has beaten DEPS consensus in 7 of the last 8 quarters, with an average positive surprise of ~1.3%; the Q1 2026 beat of +3.3% was the largest in the trailing 8-quarter window, driven by stronger organic growth, a lower tax rate, and buyback-driven share count reduction.
Quarter | Reported | Consensus | Surprise (bps) | Result |
Q1 2026 | 6% | 4.6% | +140 bps | Beat |
Q4 2025 | 4% | 5.3% | -130 bps | Miss |
Q3 2025 | 6% | 7.7% | -170 bps | Miss |
Q2 2025 | 7% | 6.3% | +70 bps | Beat |
Q1 2025 | 5% | 5.0% | 0 bps | In Line |
Q4 2024 | 7% | 5.7% | +130 bps | Beat |
Q3 2024 | 4% | 4.7% | -70 bps | Miss |
Q2 2024 | 4% | 5.0% | -100 bps | Miss |
Organic growth has been the more volatile KPI — ROP has beaten in 4 of the last 8 quarters and missed in 4, with the Q1 2026 beat of +140 bps being the largest positive surprise in the window; the Q2 2026 consensus of ~4.3% is well below the full-year 5–6% guide, reflecting management's explicit warning of a timing-driven Q2 dip in Application Software nonrecurring perpetual revenue.
Source: Visible Alpha Consensus and Actuals Data.
Key Takeaway: Management's posture is unchanged since the Q1 call — guidance was raised meaningfully post-Q1 but no further updates have been issued; the tone remains deliberately conservative with no recovery assumptions baked in for Deltek GovCon, DAT freight, or Neptune.
Metric | Initial Guidance (Q1 2026 Earnings Call, Apr 23) | Revised Guidance | Current Consensus | Note |
Q2 2026 Adj. DEPS | $5.25–$5.30 | — | $5.28 | No post-earnings update; consensus sits just above midpoint of $5.275 |
FY 2026 Adj. DEPS | $21.80–$22.05 (raised from $21.30–$21.55) | — | $21.94 | Raised $0.50 at midpoint on Q1 call; consensus slightly above midpoint of $21.925 |
FY 2026 Total Revenue Growth | ~8% | — | ~8% (implied by $8.55B consensus) | Maintained; no change since Q1 call |
FY 2026 Organic Revenue Growth | 5–6% | — | ~5.6% | Maintained; consensus within guided range |
Deltek GovCon Recovery | No recovery assumed | — | N/A | Management explicitly not baking in GovCon inflection or OBBB benefit; will adjust as conditions warrant |
DAT Freight Recovery | No meaningful recovery assumed | — | N/A | Green shoots noted (spot rates +20–30% YoY, carrier ecosystem grew Q1 for first time in years) but diesel spike compressed margins late Q1; no change to guidance posture |
Neptune | Modest top-line weakness vs. prior year | — | N/A | Bronze ingot inflation headwind continues; surcharge approach abandoned in favor of regular-way pricing; margin recovery expected to take a couple of quarters |
FY 2026 Tax Rate | ~21% (Q2 slightly below) | — | ~21% | Unchanged; Q2 tax rate expected slightly below 21% |
Source: ROP Q1 2026 Earnings Call Transcript (April 23, 2026).
Key Takeaway: Estimates have been essentially flat since the Q1 print — DEPS for Q2 drifted down modestly (-0.6%) while FY 2026 DEPS ticked up slightly (+0.03%), suggesting the Street has absorbed the guidance raise without meaningful incremental revision activity; consensus tracks guidance closely with no material divergence.
KPI / Period | Estimate ~5 Days Post Q1 Earnings (Apr 28, 2026) | Current Consensus (Jul 22, 2026) | Estimate Δ (%) | Initial Guidance (Q1 Call) | Current Guidance | Guidance Δ | Consensus vs. Guidance (%) |
Adj. DEPS — Q2 2026 | $5.31 | $5.28 | -0.6% | $5.25–$5.30 | Unchanged | 0% | +0.1% above midpoint |
Adj. DEPS — FY 2026 | $21.93 | $21.94 | +0.03% | $21.80–$22.05 | Unchanged | 0% | +0.1% above midpoint |
Revenue — Q2 2026 | $2,097M | $2,097M | 0.0% | ~8% total growth (FY) | Unchanged | 0% | In line |
Revenue — FY 2026 | $8,547M | $8,547M | 0.0% | ~8% total growth | Unchanged | 0% | In line |
EBITDA (Operating) — Q2 2026 | $815M | $816M | +0.1% | N/A | N/A | N/A | N/A |
Organic Growth — Q2 2026 | ~4.3% | ~4.3% | 0.0% | Lower in Q2 on timing; 5–6% FY | Unchanged | 0% | Below FY guide; consistent with Q2 commentary |
Estimates have been remarkably stable since the Q1 print, with no meaningful revision activity in either direction. The slight downward drift in Q2 DEPS (-0.6%) likely reflects minor model adjustments rather than any fundamental reassessment. Consensus tracking guidance closely with no divergence is a neutral signal — neither a setup for a large beat nor a miss.
Source: Visible Alpha Consensus and Actuals Data (as-of date: April 28, 2026 and July 22, 2026).
Key Takeaway: ROP has significantly underperformed since Q1 earnings — down ~7.4% vs. IGV +6.5% and SPY +5.5% — driven by multiple compression rather than estimate cuts, as the stock de-rated despite a clean beat-and-raise; the valuation discount to historical levels and software peers represents either a value opportunity or a structural re-rating, depending on whether organic growth can re-accelerate.
Since the Q1 2026 earnings release on April 23, 2026, ROP has declined approximately 7.4% (from ~$364 to ~$337), while the iShares Expanded Tech-Software ETF (IGV) gained 6.5% and the S&P 500 (SPY) gained 5.5%. The divergence is striking: ROP's beat-and-raise quarter — the largest EPS beat in 8 quarters — failed to generate sustained upside, with the stock initially holding near prior-close levels before selling off materially in May (reaching a low near $316 on May 13). The stock partially recovered in late June/early July, briefly touching ~$364 again on July 2, before pulling back to ~$337 as of July 22.
The underperformance appears driven by multiple compression rather than estimate cuts — FY 2026 DEPS consensus has been essentially flat since the Q1 print, while the stock has de-rated. This suggests macro/sentiment headwinds (software sector rotation, valuation concerns) and lingering skepticism about the durability of organic growth re-acceleration are weighing more than fundamentals. The stock's current level near its post-Q1 close implies the market is in a 'show-me' mode heading into Q2 results.
Chart: ROP vs. IGV (iShares Expanded Tech-Software ETF) vs. SPY — Indexed to 100 at April 23, 2026 (Q1 2026 Earnings Date). Key events marked: Q1 earnings (Apr 23), Morgan Stanley TMT Conference (Apr 29), Q2 earnings date announcement (Jul 1).
Source: Stock Price Data (Yahoo Finance). IGV selected as sector ETF given ROP's primary classification as a vertical software compounder.
Key Takeaway: Peer commentary from Q2-reporting companies (WDAY, FICO, CDNS, SSNC, INTU) is broadly constructive for ROP's vertical software portfolio — AI-driven bookings acceleration, strong recurring revenue retention, and healthy enterprise software demand are consistent themes, while GovCon and freight market dynamics remain idiosyncratic to ROP.
The following peer commentaries are from earnings calls and reports covering the current reporting quarter (Q2 2026 calendar period) or post-Q1 2026 commentary about current business conditions. These are selected for their read-through relevance to ROP's key business segments and themes.
Relevance: Enterprise SaaS demand, AI monetization, GovCon/federal sector, bookings momentum.
Relevance: Vertical software demand, AI-driven platform adoption, SaaS ARR growth, bookings trajectory.
Relevance: AI-driven software demand, agentic AI monetization models, macro environment for software, bookings strength.
Relevance: Vertical software/technology-enabled services demand, organic growth, AI monetization, macro resilience.
Key Takeaway: The most important development since Q1 earnings is the aggressive $2.2B share repurchase program (6M shares since November 2025), which mechanically supports DEPS and signals management conviction in valuation dislocation; the M&A pipeline has shifted to more proprietary opportunities as public market volatility caused sellers to pause active processes.
Key Takeaway: No open-market buys or discretionary sells by executives or directors since Q1 earnings — the only Form 4 activity was routine annual equity grants (transaction code 'A') to eight directors on May 20, 2026, which is standard compensation and carries no informational signal.
Name | Title | Transaction Type | Shares | Date | Note |
Archambeau, Shellye L. | Director | Equity Grant (Code A) | 1,191 | May 20, 2026 | Routine annual director equity compensation; not an open-market transaction |
Brinkley, Amy Woods | Director | Equity Grant (Code A) | 1,191 | May 20, 2026 | Routine annual director equity compensation; not an open-market transaction |
Esteves, Irene M. | Director | Equity Grant (Code A) | 1,191 | May 20, 2026 | Routine annual director equity compensation; not an open-market transaction |
Johnson, Robert D. | Director | Equity Grant (Code A) | 1,191 | May 20, 2026 | Routine annual director equity compensation; not an open-market transaction |
Joyce, Thomas Patrick Jr. | Director | Equity Grant (Code A) | 1,191 | May 20, 2026 | Routine annual director equity compensation; not an open-market transaction |
Murphy, John Francis | Director | Equity Grant (Code A) | 1,191 | May 20, 2026 | Routine annual director equity compensation; not an open-market transaction |
Thatcher, Laura G. | Director | Equity Grant (Code A) | 1,191 | May 20, 2026 | Routine annual director equity compensation; not an open-market transaction |
Wallman, Richard F. | Director | Equity Grant (Code A) | 1,191 | May 20, 2026 | Routine annual director equity compensation; not an open-market transaction |
All eight transactions on May 20, 2026 were routine annual equity grants to non-employee directors (Form 4 transaction code 'A' — Award/Grant, not an open-market purchase or sale). There were no open-market buys (code 'P') or open-market sells (code 'S') by any insider during the period from April 23 to July 22, 2026. The absence of discretionary insider selling is a mild positive signal — no executive is using the post-earnings window to reduce exposure. The absence of open-market buying is neutral given the company's aggressive corporate buyback program ($3.8B remaining authorization) effectively substitutes for individual insider purchases as a valuation signal.
Source: SEC Form 4 Filings Database (Insider Transaction Data).